Psoriasis is a chronic skin disease, characterized by epidermal hyperplasia, inflammation, angiogenesis and vascular remodelling. An immunohistochemical study on fifteen cryosections of psoriatic skin was performed using antibodies against VEGF, HIFl-a, CD34, Factor VIII, MMP-2, MMP-9, TIMP-l and TIMP-2. Psoriatic skin showed a diffuse VEGF positive staining (13.15± 6.6), while no expression was observed in normal epidermis. No or faint HIF-la immunostaining was detected in healthy skin, while in psoriatic skin HIF-la was diffusely expressed. A positive correlation between HIF-la and VEGF was reported in psoriatic skin (r= 0.644; p=0.010). In psoriatic sections CD34 expression was significantly higher in respect to control skin (19.15 ± 12.61 vs 3.0 ± 0.23; p= 0.04), factor VIII immunostaining also demonstrated a significant increased development of the microvasculature in comparison with healthy skin (18.39 ± 8.16 vs 7.4 ± 0.20; p= 0.033). Total MMP-2 expression of healthy skin (30± 2.26) was significantly lower in respect to the MMP-2 psoriatic skin (71.5±4.13; p= 0.0001) an4-a-positive correlation was observed between VEGF and MMP-2 in psoriatic patients (r= 0.688; p= 0.046). In psoriatic skin MMP-9 expression was significantly increased in comparison to control skin (31±3.3 vs 8±6.1; p=0.007). All cases of psoriatic skin tissue showed that TIMP-2 and TIMP-l expression statistically decreased in psoriatic skin (respectively 11±1.2 and 12±1.5) in comparison with healthy skin (respectively 15±3.2 and 53±3.8; p=O.OOOI). In conclusion, we observed that VEGF overexpression correlated with HIF-la and MMP-2 expression, underlining the role of VEGF in psoriasis as a key factor in the link between inflammation and angiogenesis.
detected histologically and clinically, suggesting that psoriasis is an angiogenesis-dependent disease (5) (6) . Conversely, there is evidence that angiogenic properties of psoriatic skin is associated with epidermal, not dermal, factors (7) and angiogenic stimulus is thought to be derived from the hyperplastic human epidermis (8) . Human keratinocytes are known to produce an array of cytokines that, among other effects, can act directly and indirectly on endothelial cells e.g. interleukin -I and -6, tumour necrosis factor-a, transforming growth factor a and~, (9) and, as more recently described, vascular endothelial growth factor (VEGF), that seems to be upregulated in psoriasis (8, (10) (11) .VEGF is a potent mitogen for endothelial cells in vivo and in vitro and, playing a central role in angiogenesis, increases microvascular permeability (10) . The hypoxia-inducible transcription factor-I (HIF-I) is a heterodimer that consists of the HIF-I a and the constitutively expressed aryl hydrocarbon receptor nuclear translocator (ARNT). Normally this protein is oxidized, ubiquitinylated and degradated in proteasome. HIF-I a is considered the main transacting factor in controlling VEGF gene trascription rate (12) (13) . Recently it has been proposed that HIF-I activation is induced not only by hypoxia but also by the pro-inflammatory cytokines such as IL-l and tumour necrosis factor alpha (TNFa), playing an important role in inflammatory diseases (14) (15) . Moreover, new blood vessels develop as a result of complex interaction among endothelial cells, angiogenic regulators and matrix-degrading proteolytic enzymes (16) (17) . Matrix metalloproteinases (MMPs) are a family of zinc-dependent enzymes that modulate the turnover of the extracellular matrix and play important roles in morphogenesis, angiogenesis, wound healing and in several disorders such as rheumatoid arthritis, tumour invasion and metastasis (18) . These enzymes are produced in a latent form or preform that requires proteolytic processing in order to be active (19) . MMP activity is further modulated by a family of naturally occurring tissue inhibitors of MMPs (TiMPs) which bind either pro-MMPs or active MMPs, thereby inhibiting the autocatalytic activation of latent enzymes, as well as the proteolytic capacity of active proteinases (20) . MMP-2 binds specifically to TIMP-2 whereas MMP-9 binds to TIMP-l (20) . MMP-2 and MMP-9 degrade basement membranes (BMs) and have been incriminated in the mechanism of tumor invasion and metastasis (21) . Previous studies suggested that cell adhesion of keratinocytes may be altered in psoriasis and these changes may involve cell-cell and cell-matrix interactions. These studies showed decreased adhesiveness between keratinocytes (22) and alterations of the BM at the epidermal-dermal interface (23) . Moreover, many of the factors inducing angiogenesis are also known as regulators of MMP gene expression (VEGF, TNFa) (24) (25) . Biosynthesis of the metalloproteinases is induced by cytokines, growth factors and matrix elements, or via cell membrane contact with other cell types (26) . The aim of this study was to evaluate VEGF, HIF-Ia, CD34, Factor VIII, MMPs and their inhibitors expression in the angiogenetic mechanism in psoriatic skin.
MATERIALS AND METHODS

Subjects
Skin punch biopsies were performed on the trunk or thighs offive healthy volunteers (mean age 31 ± 4.8 years; no history of skin disease; biopsy on normal skin) and fifteen patients affected by psoriasis vulgaris (mean age 27 ± 9.8 years; history of chronic, stable mild-moderate skin disease; biopsy on plaque active edges), after obtaining informed consent. None of the patients was receiving systemic or photo-therapy. All topical therapies, apart from emollients, were discontinued 3 weeks prior to the study.
Punch biopsy specimens (5-6 mm) were obtained from patients and healthy subjects under I% Lidocaine local anaesthesia and were snap frozen in OCT embedding compound, cooled in liquid nitrogen and stored at -80°.5 urn thick sections were cut with a cryotome and left to dry overnight in the open air, then fixed in acetone at 4°C for 10 min. The sections were incubated at room temperature with the specific antibodies: monoclonal antibody against VEGF 165 (dil I:200, Santa Cruz Biotechnologies, Santa Cruz, CA), HIF-Iu (dil 1:100, Santa Cruz Biotechnologies, Santa Cruz, CA), CD34 (dill :50, Becton Dickinson), Factor VIII (dil. 1:600, Dako s.p.a., Milano, Italy) and polyclonal antibodies anti-MMP-2, MMP-9,TIMP-I,TIMP-2 (Stetler Stevenson, Bethesda, MD) overnight at 4°C. All slides were then immunostained by using the streptoavidin-biotin peroxidase technique. Sections were incubated with 3,3-diaminobenzydine (0.05 diaminobenzydine in 0.05 M Tris buffer, ph 7.6 and 0.0 I% hydrogen peroxide) counterstained with Mayer's hematoxylin and coverslipped with Paramount.
Gastric tumour sections were used as positive control. As a negative control, primary antibodies were replaced with an equivalent concentration of normal mouse and normal rabbit IgG.
The immunoreactivity of the antibodies against VEGF, HIF-la, CD34, Factor VIII, MMP-2, MMP-9, TIMP-l, TIMP-2 was evaluated by two independent observers. The agreement between the observers were always> 95%. The epithelial cell reaction to VEGF, HIF-I a, MMP-2, MMP-9, TIMP-l and TIMP-2 was observed starting from the basal lamina through the spinous layer and was evaluated by a quantitative analysis. We counted at a light microscopy 250x magnification at least 1000 psoriatic epithelial cells in a minimum of ten fields and then expressed the percentage of positive cells counted independently from the staining intensity. For anti-CD34 and Factor VIII antibodies we counted positive endothelial cells at 250x at least in ten fields and expressed as percentage of CD34 and Factor VIII positive endothelial cells of all epithelial cells counted.
Statistical differences were assessed by the two-tailed Student's t-test for paired differences. Results are expressed as mean ± standard deviation (SD). Correlations between VEGF and HIF-la, VEGF and MMP-2 were assessed by linear regression analysis. All results were considered significant at p<0.05.
RESULTS
Immunohistochemical results for VEGF, C034, Factor VIII and HIF-la are summarized in Table I . MMPs and TIMPs immunohistochemical results are summarized in Table II .
VEGF
Psoriatic skin keratinocytes showed a diffuse cytoplasmatic positive staining for VEGF, although more intensively expressed in the basal and suprabasal layer (Fig. lA) , and the percentage of positive cells was 13.15 ± 6.6. Moreover VEGF was intensively expressed by dermal inflammatory and endothelial cells. On the contrary, no VEGF was expressed in the epidermis of any of the normal volunteers.
CD34
In psoriatic sections, C034 stained new vessels with uniform intensity throughout the dermal plexus. Moreover, in the tip of the papillae an increased tortuosity of the capillary loop was evidenced ( Fig.  IB) . In control skin a lower percentage of C034+ endothelial vessels was observed in respect to psoriatic skin (p= 0.04).
Factor VIII
In healthy skin the mean value ofFactor VIII positive endothelial cells was 7.4 ± 0.2. In psoriatic patients factor VIII immunostaining demonstrated a significant increased development of the microvasculature in comparison with healthy (p= 0.033).
HIF-Ia
No HIF-Ia immunostaining was detected in the cytoplasm of healthy skin, only in a few cases we observed a faint and focal HIF -I a expression in the basal layer ( Fig. IC) . In the epidermis of psoriatic skin HIF-Ia was diffusely expressed ( Fig. 10 ). Moreover, a positive correlation between HIF-Ia and VEGF was reported in psoriatic skin (r= 0.644, p=O.OIO; Fig.2 ).
Metalloproteinases and their inhibitors
Immunoreactivity with anti-MMP-2 antibody 10 psoriatic skin sections showed a diffused intracytoplasmatic staining in keratinocytes, with a stronger immunoreactivity in the suprabasal layer of the viable epidermis compared with the basal layer. In the all samples of skin tissue from healthy subjects MMP-2 immunoreactivity was observed in particular in the cytoplasm of keratinocytes of basal layer (Fig. IE) . Total MMP-2 expression of healthy skin (30 ± 2.26) was significantly lower in respect to the MMP-2 psoriatic skin (71.5 ± 4.13, p= 0.0001).
A positive correlation was observed between VEGF and MMP-2 in psoriatic patients (r= 0.688; p= 0.046; Fig. 3 ). Briefly, high VEGF levels correspond to high MMP-2 levels and vice versa.
In psoriatic skin MMP-9 expression was significantly increased in comparison to control skin (p=0.007) with a strong cytoplasmic immunoreactivity in the basal layer and a faint staining in the suprabasal layer (Fig. IF) . In normal skin we observed a diffuse cytoplasmatic positive staining for MMP-9 throughout the epidermis. All cases of psoriatic skin tissue showed faint expression ofTIMP-l and TIMP-2 in basal and suprabasallayers.
In normal skin TIMP-l immunoreactivity was markedly expressed in the keratinocytes of basal layer, while it was not present in the suprabasal layer at all. The staining for TIMP-2 appears to be less pronounced in the basal layer of normal skin compared to TIMP-l staining, whereas the suprabasallayer showed no immunoreactivity.
Total TIMP-I immunostaining was statistically decreased in psoriatic skin (12 ± 1.5) with respect to healthy skin (53 ± 3.8, p=O.OOOI). DISCUSSION Several studies have been established that angiogenesis is of critical importance for tumor progression, tissue repair and in the pathogenesis of inflammatory diseases (27) . Many pro-angiogenic mediators are up-regulated in inflamed skin (28) . In psoriasis, VEGF might play a causative role in the vascular changes and also in epidermal and inflammatory alterations that characterize the disease (29) . Our study adds evidence to the important role of this factor, which in animal models is able to induce lesions that recapitulate human disease (29) . We observed a significant overexpression of VEGF in the basal and spinous layer of psoriatic epidermis compared to normal skin, thus confirming previously reported studies (8) . Moreover, our data showed that cutaneous angiogenesis in psoriatic patients not only involves vascular enlargement and increased tortuosity of the capillary loop, but is also associated with a significant increase of microvasculature, as evidenced by CD34 immunostaining, which marks specifically the newly formed vessels (30) .
Our results indicate that VEGF is produced by keratinocytes themselves in an autocrine loop and not by stromal cells in a paracrine loop. In this way VEGF meets the increased nutritional needs of the hyperplastic psoriatic epidermis. As suggested by other studies (31) , VEGF might help in maintaining cell viability and impeding cellular damage induced by toxic substances, as ROS-generating molecules, that are highly produced in psorias is (31) . Keratinocyte cell-derived VEGF probably contributes actively to the pathogenesis of psoriasis via the induction of permeability in dermal vessels, its chemotactic action on inflammatory cells and endothelial cells, and its angiogenic effects (8, 32) . Although it is unclear how VEGF could lead to epidermal changes, it seems likely that the inflamed vasculature, which exhibits elevations in vascular adhesion molecules such as E-selectin, ICAM-I and VCAM-I, plays a primary role by promoting the extravasation of inflammatory cells to the skin which then lend their own cytokine and chemokine mediators to the development of the psoriatic proces s (29) .
In psoriasis, the factors capable of inducing VEGF have not yet been identified so far. In tumors it is induced by different factors such as nitric oxide. glucose, hormones, cytokines, angiogenic stimuli them selves and hypoxia. HIF-l is the main transacting factor in controlling the rate of VEGF gene trascnption (12) (13) . Interestingly, we found that HIF-l a is usually not expressed or in few cases is confined to the basal layer in healthy skin, whereas in psoriasis it is correlated with VEGF expression in the epidermis. This finding shows evidence of a close relationship between the two factors in psoriasis. Although signalling through the HIF-I a pathway has been studied primarily in the context of cellular adaptation to hypoxia, accumulating data suggest that pro-inflammatory mediators can also upregulate HIF-la protein expression and HIF-I DNA-binding activity (15) . Recently, cytokines such as IL-I~, TNF-a and interferon-gamma, have been shown to increase HIF-l DNA binding activity even in nonnoxic conditions ( 14) . The cutaneous and systemic overexpression of several proinflammatory cytokines, such as IFN-gamma and TNF-a, has been demonstrated in psoriasis and is considered to be respon sible for initiation, maintenance and recurrence of skin lesions. The cellular composition of the inflammatory infiltrate within the plaques as well as the keratinocyte hyperplasia also appear to be directed by cytokines (33) . TNF-a is able to induce a cascade of other cytokines including IL-l, IL-RA, IL-2, IL-4, IL-6, and IL-23 release (34) . Moreover TNF-a regulates keratinocyte adhesion and migration by inducing integrins and proteins that affect both polymerisation and disassembly (35) . It is conceivable that all these cytokines can be involved in the upregulation ofHIFa and VEGF in psoriasis. We also found that psoriatic skin shows overexpression of MMP2 compared to normal skin, according to others (36) (37) , and that this molecule was directly correlated with VEGF. MMPs act as key effectors and regulators of tissue remodelling and cell migration (38) because the complex process of migration requires both a formation of cell-matrix adhesion at the leading edge and their dissolution at the rear end of the moving cell (39) . Many ofthe factors inducing angiogenesis, including VEGF and TNF-a, are also known as regulators of MMP gene expression (24) (25) . MMP-2 plays a role in the remodelling of the endothelial cell membrane (ECM) and is of particular importance to angiogenesis, possibly through its ability to bind the vitronectin receptor aup3 expressed on the surface of endothelial cells undergoing angiogenesis (40) . It is also important for keratinocyte migration (41) adhesion and' proliferation (4r'l}. A study on normal keratinocyte cultures speculated that MMP-2 is secreted by keratinocytes when in an undifferentiated state (43) , this could help us to understand the presence of MMP-2 in the upper layer of psoriatic skin where there is an impaired differentiation. Moreover, others hypothesized a possible role of MMP-2 related to cell-cell and cell matrix changes associated to a primary alteration in keratinocytes in psoriatic epidermis (37) .
In our psoriatic samples we also observed an increased MMP-9 expression in the basal layer with respect to normal skin, in accordance with the data of Hitchon (44) . These results could be explained by upregulation of cytokines, such as epidermal growth factor (EGF) or scatter factor/hepatocyte growth factor (SF/HGF), on MMP-9 activity (45) (46) . It has recently been reported that during inflammatory processes, TGF-p induces the expression of pro-MMP-9. The MMP-9 retains its latency by forming a complex with TIMP-l, which prevents its access to the tissue-associated activator, pM9A. When TNFa is also present, it down regulates TIMP-l (47) . It has previously been demonstrated that MMP-9 is up-regulated during wound repair process and is detected in migrating basal epithelial cells (48) . On the other hand, it has been shown that a deficiency in MMP-9 actually accelerates the rate of normal wound resurfacing, suggesting that MMP-9 exerts a negative control over cell migration (49) .
MMP activities are regulated at multiple levels from their expression to activation by cleavage of the inhibitory domain as well as blockage by tissue inhibitors (TIMPs). In control skin, according to literature (50) (51) , we observed TIMP-s expression only in the basal cell layer of epidermis. Conversely, in the all samples of psoriatic skin tissue we observed a faint expression of TIMP-l and TIMP-2 in basal and suprabasal layers. The low presence of TIMPs in psoriatic epidermis could be of particular interest since it has been shown that inhibitors of MMP activity decrease angiogenesis in vitro (52) . TIMPs exert several biochemical and physiological! biological functions, including inhibition of active MMPs, proMMP activation, cell growth promotion, matrix binding, the induction of apoptosis (53) and the regulation of cell proliferation and survival (54) .
In conclusion, we observed an impairment of the mechanism of MMPs regulation in psoriasis, and, interestingly, VEGF overexpression correlated with HIF-Iu and MMP-2 expression. These findings in psoriasis suggest that VEGF may play an important role in the link between inflammation and angiogenesis, hypothesizing that chronic inflammation and angiogenesis are co-dependent and that one may modulate both processes by an action on either one alone in psoriasis.
